Company: Light Sciences Oncology
Based: Bellevue, WA
Investors: Novo, Essex Woodlands Health Ventures, Undisclosed Firm, Undisclosed Firm, Adams Street Partners, Undisclosed Firm
Scoop: Light Sciences Oncology, which is developing Light Infusion Therapy (Litx) to treat cancer and other conditions, closed its Series C round of financing in July. Researchers at the company are undertaking two Phase III clinical trials in patients with hepatocellular carcinoma and metastatic colorectal cancer. There's also a planned Phase III trial in glioblastoma multiforme, and early stage clinical trials in benign prostatic hyperplasia.